Therefore, we re-measured circulating Ang-2, cytokines, and adhesion molecules in blood samples from a placebo-controlled interventional trial on pharmacologic p38 mitogen-activated protein (MAP) kinase inhibition during experimental human endotoxemia [21]. This evidence concerns the gene ANGPT2 and serum lipopolysaccharide activity.